Objective: Obsessive-compulsive disorder (OCD) is one of the most common mental disorders with a loss of functionality in many areas of life. The current study aims to reveal the relationship between occupational functionality and metacognition in OCD patients.

Materials And Methods: The cross-sectional study sample consisted of 183 participants diagnosed with OCD according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) criteria. Participants were evaluated with the Yale-Brown Obsession and Compulsion Scale (Y-BOCS), Beck Depression Inventory (BDI), Beck Anxiety Inventory (BAI), and Metacognition Scale (MCQ-30). The occupational functioning of the participants was determined by the basic version of the semi-structured Longitudinal Follow-up Evaluation form (LIFE-BASE) in interviews with the clinician. The LIFE-BASE form divided the study sample into functional (n=92) and non-functional (n=91).

Results: It was determined that the mean age of the study sample was 32.49±8.65 years, and 54.1% (n=99) of them were female. When the two groups were compared, statistically significant differences were found in gender (p<0.001), education (p=0.012), Y-BOCS compulsion (p=0.003), and total scores (p=0.006). In the comparison of the groups, a statistical difference was found between the MCQ-30 Positive Beliefs subscale (p<0.05). However, no statistical difference was found between uncontrollability and danger, cognitive confidence, belief in controlling thoughts, and cognitive awareness. In addition, it was found that gender and the MCQ-30 positive beliefs score could predict occupational functioning.

Conclusion: The present study is important because it was the first study to show the effects of positive beliefs on occupational functioning in OCD patients. However, further studies are needed on the underlying causes of this effect.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10840066PMC
http://dx.doi.org/10.7759/cureus.51738DOI Listing

Publication Analysis

Top Keywords

study sample
12
relationship occupational
8
occupational functionality
8
functionality metacognition
8
obsessive-compulsive disorder
8
mental disorders
8
metacognition patients
4
patients obsessive-compulsive
4
disorder objective
4
objective obsessive-compulsive
4

Similar Publications

Drug Development.

Alzheimers Dement

December 2024

Department of Anesthesiology and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, U.S.A., Philadelphia, PA, USA.

Background: The vicious cycle between depression and dementia increases the risk of Alzheimer's Disease (AD) pathogenesis and pathology. This study investigates therapeutic effectiveness versus side effects and the underlying mechanisms of intranasal dantrolene nanoparticles (IDNs) to treat depression behavior and memory loss in 5XFAD mice.

Method: 5XFAD and wild-type B6SJLF1/J mice were treated with IDNs (IDN, 5 mg/kg) in Ryanodex formulation for a duration of 12 weeks.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Karolinska Institute, Stockholm, Södermanland and Uppland, Sweden.

Background: Novel anti-amyloid therapies (AAT) for Alzheimer's Disease (AD) have recently been approved in the United States, Japan and China, and are under regulatory review in Europe. Questions remain regarding the long-term effectiveness and value of these drugs when used in routine clinical practice. Data from follow-up studies will be important to inform their optimal use, including criteria for treatment initiation, monitoring strategies, stopping rules, pricing and reimbursement considerations.

View Article and Find Full Text PDF

Drug Development.

Alzheimers Dement

December 2024

Department of Bioengineering, University of California, Los Angeles, CA, USA, Los Angeles, CA, USA.

Background: The initiation of amyloid plaque deposition signifies a crucial stage in Alzheimer's disease (AD) progression, which often coincides with the disruption of neural circuits and cognitive decline. While the role of excitatory-inhibitory balance is increasingly recognized in AD pathophysiology, targeted therapies to modulate this balance remain underexplored. This study investigates the effect of perampanel, a selective non-competitive AMPA receptor antagonist, in modulating neurophysiological changes in hAPP-J20 transgenic Alzheimer's mice.

View Article and Find Full Text PDF

Background: Identifying strategies to engage with potential participants is critical for efficient enrollment in Alzheimer's Disease (AD) trials. Previous studies link faster speed of first contact with successful phone interview completion for Major Depressive Disorder (MDD) participants. This has not been examined in AD participants.

View Article and Find Full Text PDF

Background: Alzheimer's disease neuropathology involves the deposition in brain of aggregates enriched with microtubule-binding-region (MTBR) of tau adopting an abnormal conformation between residues 306-378 in the core of aggregates. Anti-tau drugs targeting around this domain have the potential to interfere with the cell-to-cell propagation of pathological tau. Bepranemab is a humanized monoclonal Ig4 antibody binding to tau residues 235-250.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!